Home › Calculator › INTS Dividend Calculator 2026
INTS Dividend DRIP Calculator 2026
50.76% YieldHealthcareIntensity Therapeutics, Inc. · NASDAQ
Price: $3.94 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When INTS pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your INTS snowball 📈
$10,000 in INTS → $606.6K in 10 years · $17,020.20/month
About Intensity Therapeutics, Inc. (INTS) — Dividend Analysis 2026
Intensity Therapeutics, Inc. is a biotechnology enterprise in the clinical development phase, dedicated to discovering, advancing, and commercializing pharmaceutical treatments for solid tumor cancers. The company's primary experimental compound, INT230-6, is presently undergoing Phase 2 clinical trials. This investigational drug targets a range of difficult-to-treat solid tumors, including those affecting the pancreas, colon, bile duct, as well as squamous cell, sarcoma, breast, and liver cancers. Intensity Therapeutics has formed strategic collaborations with major pharmaceutical companies and research institutions: A partnership with Merck Sharpe & Dohme Corp. focuses on evaluating INT230-6 in conjunction with Keytruda for advanced pancreatic, colon, squamous cell, and bile duct malignancies. Another collaboration with Bristol-Myers Squibb Company is dedicated to studying INT230-6 combined with Yervoy in patients suffering from advanced liver, breast, and sarcoma cancers. Furthermore, the company is working with the Ottawa Hospital Research Institute and the Ontario Institute of Cancer Research on a randomized controlled Phase II neoadjuvant study of INT230-6 for women diagnosed with early-stage breast cancer. Established in 2012, Intensity Therapeutics maintains its corporate headquarters in Westport, Connecticut.
Compare INTS with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full INTS DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open INTS position with:
🌍 INTS Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold INTS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 50.76% | 47.96% | $5,076 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 43.15% | 40.35% | $4,315 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 40.61% | 37.81% | $4,061 / yr |
| 🇬🇧 UK ISA | 0% | 50.76% | 47.96% | $5,076 / yr |
| 🇬🇧 UK Taxable | 8.75% | 46.32% | 43.52% | $4,632 / yr |
| 🇨🇦 TFSA | 0% | 50.76% | 47.96% | $5,076 / yr |
| 🇨🇦 CA Taxable | 25% | 38.07% | 35.27% | $3,807 / yr |
| 🇦🇺 Super (pension) | 15% | 43.15% | 40.35% | $4,315 / yr |
| 🇦🇺 AU Taxable | 30% | 35.53% | 32.73% | $3,553 / yr |
| 🇩🇪 DE Taxable | 26.375% | 37.37% | 34.57% | $3,737 / yr |
| 🇫🇷 FR Taxable | 30% | 35.53% | 32.73% | $3,553 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 INTS Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 INTS Dividend Payment Schedule
INTS pays quarterly — 4 times per year. Next ex-div: TBD.
📊 INTS vs Healthcare Benchmarks
How INTS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for INTS sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ INTS Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-07-16 | 5,500 | $4.90 | $26.9K | ||
| A-Award | 2026-07-16 | 5,500 | $4.90 | $26.9K | ||
| A-Award | 2026-07-16 | 5,500 | $4.90 | $26.9K | ||
| A-Award | 2026-07-16 | 5,500 | $4.90 | $26.9K | ||
| A-Award | 2026-07-16 | 11,000 | $4.90 | $53.9K | ||
| A-Award | 2026-07-16 | 34,000 | $4.90 | $166.6K | ||
| A-Award | 2026-07-16 | 78,000 | $4.90 | $382.2K | ||
| A-Award | 2026-06-30 | 3,688 | $3.48 | $12.9K | ||
| A-Award | 2026-06-30 | 1,093 | $3.48 | $3.8K | ||
| A-Award | 2026-03-26 | 37,749 | $6.11 | $230.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the INTS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Intensity Therapeutics, Inc. (INTS) is currently trading at $3.94, trading near its 52-week low. The current dividend yield is 50.76% based on an annual payout of $2.00 per share.
INTS (Intensity Therapeutics, Inc.) — 50.76% Dividend Yield Analysis
Intensity Therapeutics, Inc. (INTS) is a healthcare stock currently trading at $3.94 with a dividend yield of 50.76%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (50.76%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.